Kumar Ravindra 4
4 · ACCELERON PHARMA INC · Filed Mar 5, 2018
Insider Transaction Report
Form 4
Kumar Ravindra
VP & Chief Scientific Officer
Transactions
- Award
Common Stock
2018-03-01+4,463→ 97,138 total - Award
Option to Purchase Common Stock
2018-03-01+26,775→ 26,775 totalExercise: $40.61Exp: 2028-03-01→ Common Stock (26,775 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award vest in equal quarterly installments over the four years after January 1, 2018.